This inventor holds 1 USPTO granted patent. Top assignee: Morgan Stanley Senior Funding, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Bart ECG De Goeij: Innovator in Cancer Treatment
Introduction
Bart ECG De Goeij is a notable inventor based in Utrecht, Netherlands. He has made significant contributions to the field of cancer treatment through his innovative research and development. His work focuses on the application of antibodies in medical therapies.
Latest Patents
Bart ECG De Goeij holds a patent for a groundbreaking method of treating cancer by administering an antibody that binds to 5T4. This patent represents a significant advancement in the fight against cancer, showcasing his commitment to improving patient outcomes.
Career Highlights
Currently, Bart is employed at Morgan Stanley Senior Funding, Inc., where he continues to apply his expertise in innovative solutions. His career reflects a dedication to advancing medical technology and improving therapeutic strategies.
Collaborations
Throughout his career, Bart has collaborated with talented professionals, including David Satijn and Esther CW Breij. These partnerships have fostered a collaborative environment that enhances the development of innovative treatments.
Conclusion
Bart ECG De Goeij is a prominent figure in the field of cancer treatment, with a focus on innovative antibody therapies. His contributions and collaborations highlight the importance of teamwork in advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile